Peterson Matthew L, Hickey Magali B, Zaworotko Michael J, Almarsson Orn
TransForm Pharmaceuticals Inc. Lexington, MA 02421, USA.
J Pharm Pharm Sci. 2006;9(3):317-26.
The commentary seeks to provide a brief history and perspective on the importance of crystal forms of pharmaceuticals as a means of achieving performance criteria. The expanding scope of crystal form selection, emergence of crystal engineering in pharmaceutical science and pharmaceutical co-crystals are topics of this brief review.
本评论旨在简要介绍药物晶型作为实现性能标准手段的重要性的历史和观点。晶型选择范围的扩大、药物科学中晶体工程的出现以及药物共晶是本简要综述的主题。